Pharsight Monthly Summary
APRIL, 2024
Recent happenings in patent protected drugs.
spacer_11
At a Glance
98
drug patents lapsed
Photos
109
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
AAA USA INC
 
ABBVIE
 
ACTELION
 
AKEBIA
 
ALKERMES INC
 
AM REGENT
 
AMGEN INC
 
ASTELLAS
 
AXSOME
 
AXSOME MALTA
 
BLUEPRINT MEDICINES
 
CHEMOCENTRYX
 
CHIESI
 
DAY ONE BIOPHARMS
 
DECIPHERA PHARMS
 
ELI LILLY AND CO
 
ESPERION THERAPS INC
 
EXELTIS USA INC
 
FENNEC PHARMS INC
 
GENENTECH INC
 
GILEAD SCIENCES INC
 
GLOBAL BLOOD THERAPS
 
IDORSIA
 
ITALFARMACO SPA
 
JANSSEN BIOTECH
 
JANSSEN PRODS
 
LOXO ONCOL ELI LILLY
 
LUMICELL
 
MAYNE PHARMA
 
MITSUBISHI TANABE
 
NEOS THERAPS
 
NOVARTIS
 
PURDUE PHARMA LP
 
SPRINGWORKS
 
SUMITOMO PHARMA
 
SUN PHARM
 
TOLMAR
 
VANDA PHARMS INC
 
VERTEX PHARMS INC
 
 
spacer_11
Drugs not protected by their main patents
Drug Company
ABILIFY OTSUKA
ABILIFY MYCITE KIT OTSUKA
ADASUVE ALEXZA PHARMS
ADDYI SPROUT PHARMS
ADLYXIN SANOFI-AVENTIS US
AGGRASTAT MEDICURE
ALDARA BAUSCH
ARNUITY ELLIPTA GLAXOSMITHKLINE
AURYXIA KERYX BIOPHARMS
AXUMIN BLUE EARTH
BRILINTA ASTRAZENECA
CLEVIPREX CHIESI
COPAXONE TEVA PHARMS USA
DALIRESP ASTRAZENECA
DEXILANT TAKEDA PHARMS USA
DEXILANT SOLUTAB TAKEDA PHARMS USA
DIPRIVAN FRESENIUS KABI USA
ELELYSO PFIZER
EMEND MSD MERCK CO
EPIVIR VIIV HLTHCARE
FERAHEME COVIS
FLONASE SENSIMIST ALLERGY RELIEF HALEON US HOLDINGS
GADAVIST BAYER HLTHCARE
GILENYA NOVARTIS
GLEEVEC NOVARTIS
IQIRVO IPSEN
IRESSA ASTRAZENECA
JADENU SPRINKLE NOVARTIS
JUXTAPID CHIESI
LEVEMIR FLEXTOUCH NOVO NORDISK INC
LIPTRUZET ORGANON
LUMASON BRACCO
LYRICA CR UPJOHN
MACRILEN NOVO
MOVIPREP SALIX PHARMS
MYRBETRIQ GRANULES APGDI
NEXIUM 24HR ASTRAZENECA LP
NORDITROPIN FLEXPRO NOVO NORDISK INC
NOURIANZ KYOWA KIRIN
NOVOLOG FLEXTOUCH NOVO NORDISK INC
NOXAFIL MERCK SHARP DOHME
OMONTYS TAKEDA PHARMS USA
OMONTYS PRESERVATIVE FREE TAKEDA PHARMS USA
ORBACTIV MELINTA THERAP
PEPAXTO ONCOPEPTIDES AB
RAPIVAB BIOCRYST
REYATAZ BRISTOL MYERS SQUIBB
SAXENDA NOVO
SELZENTRY VIIV HLTHCARE
SOLIQUA 100/33 SANOFI-AVENTIS US
SOMAVERT PHARMACIA
SPIRIVA RESPIMAT BOEHRINGER INGELHEIM
SYNRIBO TEVA PHARMS INTL
TORISEL PF PRISM CV
TRUVADA GILEAD
VARITHENA PROVENSIS
VASCEPA AMARIN PHARMS
VELPHORO VIFOR FRESENIUS
VENLAFAXINE BESYLATE ALMATICA
VICTRELIS MERCK SHARP DOHME
VIIBRYD ABBVIE
VYVANSE TAKEDA PHARMS USA
XARELTO JANSSEN PHARMS
XEGLYZE HATCHTECH
XEPI FERRER INTERNACIONAL
XOPENEX HFA LUPIN
XTORO FONSECA BIOSCIENCES
ZYVOX PFIZER
Drug patents lapsed
Drug Patent Patent expiry
ALDARA 7696159 Apr, 2024
ARIKAYCE KIT 8802137 Apr, 2024
ARIKAYCE KIT 9827317 Apr, 2024
BOSULIF RE42376 Apr, 2024
BOSULIF RE42376 Apr, 2024
BOSULIF RE42376 Apr, 2024
BOSULIF RE42376 Apr, 2024
BOSULIF RE42376 Apr, 2024
BYDUREON 7563871 Apr, 2024
BYDUREON 9238076 Apr, 2024
BYDUREON BCISE 7563871 Apr, 2024
BYDUREON BCISE 9238076 Apr, 2024
BYDUREON PEN 7563871 Apr, 2024
BYDUREON PEN 9238076 Apr, 2024
CONTRAVE 11278544 Apr, 2024
DEXILANT 8722084*PED Apr, 2024
DEXILANT 8784885*PED Apr, 2024
DEXILANT 8722084*PED Apr, 2024
DEXILANT 8784885*PED Apr, 2024
DEXILANT SOLUTAB 8784885*PED Apr, 2024
DURYSTA 10398707 Apr, 2024
DUTREBIS 7169780*PED Apr, 2024
EVEKEO ODT 10130580 Apr, 2024
EVEKEO ODT 10130580 Apr, 2024
EVEKEO ODT 10130580 Apr, 2024
EVEKEO ODT 10130580 Apr, 2024
EVEKEO ODT 10130580 Apr, 2024
EXSERVAN 8603514 Apr, 2024
FARXIGA 9238076 Apr, 2024
FARXIGA 9238076 Apr, 2024
GONAL-F RFF PEN 7741268 Apr, 2024
GONAL-F RFF PEN 7741268 Apr, 2024
GONAL-F RFF PEN 7741268 Apr, 2024
IONSYS 6975902 Apr, 2024
ISENTRESS 7169780*PED Apr, 2024
ISENTRESS 7169780*PED Apr, 2024
ISENTRESS 7169780*PED Apr, 2024
ISENTRESS 7169780*PED Apr, 2024
ISENTRESS HD 7169780*PED Apr, 2024
KYNMOBI 8603514 Apr, 2024
KYNMOBI 8603514 Apr, 2024
KYNMOBI 8603514 Apr, 2024
KYNMOBI 8603514 Apr, 2024
KYNMOBI 8603514 Apr, 2024
MAVENCLAD 7888328 Apr, 2024
MAVENCLAD 8785415 Apr, 2024
MEGACE ES 7101576 Apr, 2024
MEGACE ES 9040088 Apr, 2024
MEGACE ES 9101540 Apr, 2024
MEGACE ES 9101549 Apr, 2024
MEGACE ES 9107827 Apr, 2024
OFEV 7989474 Apr, 2024
OFEV 7989474 Apr, 2024
ONZETRA XSAIL 9119932 Apr, 2024
ORACEA 8394405 Apr, 2024
ORACEA 8394406 Apr, 2024
ORACEA 8470364 Apr, 2024
ORACEA 8709478 Apr, 2024
PROBUPHINE 7736665 Apr, 2024
RAYOS 8309124 Apr, 2024
RAYOS 8394407 Apr, 2024
RAYOS 9040085 Apr, 2024
RAYOS 9186332 Apr, 2024
RAYOS 8309124 Apr, 2024
RAYOS 8394407 Apr, 2024
RAYOS 9040085 Apr, 2024
RAYOS 9186332 Apr, 2024
RAYOS 8309124 Apr, 2024
RAYOS 8394407 Apr, 2024
RAYOS 9040085 Apr, 2024
RAYOS 9186332 Apr, 2024
RELISTOR 10376584 Apr, 2024
RELISTOR 8552025 Apr, 2024
RELISTOR 9669096 Apr, 2024
RELISTOR 10376584 Apr, 2024
RELISTOR 8552025 Apr, 2024
RELISTOR 9669096 Apr, 2024
RELISTOR 10376584 Apr, 2024
RELISTOR 8552025 Apr, 2024
RELISTOR 9669096 Apr, 2024
ROBINUL 7091236 Apr, 2024
ROBINUL FORTE 7091236 Apr, 2024
SOOLANTRA 11033565 Apr, 2024
SOOLANTRA 7550440 Apr, 2024
SOOLANTRA 8080530 Apr, 2024
SOOLANTRA 8093219 Apr, 2024
SOOLANTRA 8415311 Apr, 2024
SOOLANTRA 8470788 Apr, 2024
SOOLANTRA 8815816 Apr, 2024
SUBOXONE 8603514 Apr, 2024
SUBOXONE 8603514 Apr, 2024
SUBOXONE 8603514 Apr, 2024
SUBOXONE 8603514 Apr, 2024
SYMPAZAN 8603514 Apr, 2024
SYMPAZAN 8603514 Apr, 2024
SYMPAZAN 8603514 Apr, 2024
TOBI PODHALER RE47526 Apr, 2024
XHANCE 8522778 Apr, 2024
Newly introduced Drug Patents
Drug Patent Patent expiry
ADZENYS XR-ODT 9839619 Jun, 2032
AUVELITY 11969421 Nov, 2034
AYVAKIT 11964980 Apr, 2040
CEQUA 11951153 Feb, 2037
DROSPIRENONE 11951213 Jun, 2031
DUVYZAT 10688047 Oct, 2036
DUVYZAT 7329689 Jan, 2025
DUVYZAT 9421184 Feb, 2032
DUVYZAT 9867799 Feb, 2032
EDURANT PED 11065198 Oct, 2037
EDURANT PED 7125879 Apr, 2025
ELIGARD KIT 11931559 Dec, 2041
ENTRESTO SPRINKLE 10722471 Feb, 2037
ENTRESTO SPRINKLE 8101659 Jan, 2025
ENTRESTO SPRINKLE 8877938 May, 2027
ENTRESTO SPRINKLE 9388134 Nov, 2026
ERLEADA 11963952 Jan, 2040
EVRYSDI 11938136 Nov, 2036
FABHALTA 11951101 Jul, 2041
FENSOLVI KIT 11931559 Dec, 2041
LUMISIGHT 10285759 Dec, 2031
LUMISIGHT 9032965 Dec, 2031
LUMISIGHT 9155471 Oct, 2031
LUMISIGHT 9532835 Dec, 2031
LUMISIGHT 9763577 Sep, 2034
LUTATHERA 10596276*PED Jan, 2039
LUTATHERA 10596278*PED Jan, 2039
LUTATHERA 11904027*PED Jan, 2039
LYBALVI 11951111 Nov, 2041
MAYZENT 11944602 Jul, 2036
MULTRYS 11975022 Jul, 2041
MYCAPSSA 11969471 Sep, 2029
MYFEMBREE 11957684 Sep, 2037
NEXLETOL 11744816 Mar, 2036
NEXTSTELLIS 11957694 Jun, 2036
NEXTSTELLIS 11964055 Jun, 2036
OGSIVEO 10590087 Aug, 2039
OGSIVEO 10710966 Aug, 2039
OGSIVEO 10941118 Aug, 2039
OGSIVEO 11504354 Jul, 2042
OGSIVEO 11612588 Jul, 2042
OGSIVEO 11807611 Sep, 2042
OGSIVEO 11820748 Aug, 2039
OGSIVEO 11844780 Sep, 2042
OGSIVEO 11845732 Aug, 2039
OGSIVEO 11872211 May, 2043
OGSIVEO 11884634 Aug, 2039
OGSIVEO 11884635 Aug, 2039
OGSIVEO 11905255 Aug, 2039
OGSIVEO 11925619 May, 2043
OGSIVEO 11925620 May, 2043
OGSIVEO 11938116 May, 2043
OGSIVEO 11951096 May, 2043
OGSIVEO 11957662 May, 2043
OGSIVEO 7342118 Aug, 2025
OGSIVEO 7795447 Aug, 2025
OGSIVEO 7951958 Mar, 2025
OJEMDA 10426782 Jun, 2035
OJEMDA 8293752 Aug, 2031
OPSYNVI 10946015 Sep, 2026
OPSYNVI 7094781 Dec, 2025
OPSYNVI 8268847 Apr, 2029
OTEZLA 10092541*PED Nov, 2034
OTEZLA 7427638*PED Aug, 2028
OTEZLA 9872854*PED Nov, 2034
OXBRYTA 11944612 Dec, 2036
OXYCONTIN 11964056 Aug, 2027
PEDMARK 11964018 Jul, 2039
PONVORY 11951097 Oct, 2042
QINLOCK 11969414 Feb, 2041
QINLOCK 11969415 Dec, 2040
RADICAVA ORS 11957660 Nov, 2039
RETEVMO 10112942 Oct, 2037
RETEVMO 10137124 Oct, 2037
RETEVMO 10172851 Oct, 2037
RETEVMO 10584124 Oct, 2038
RETEVMO 10786489 Oct, 2038
SLYND 11951213 Jun, 2031
SUNLENCA 11944611 Jun, 2041
SUNLENCA 11944611 Jun, 2041
SUNOSI 11969404 Mar, 2040
SYMDEKO (COPACKAGED) 11951212 Apr, 2035
TAVNEOS 11951214 Nov, 2039
TRALEMENT 11975022 Jul, 2041
TRYVIO 10919881 Feb, 2038
TRYVIO 11174247 Nov, 2037
TRYVIO 11680058 Jul, 2038
TRYVIO 11787782 Mar, 2038
TRYVIO 8324232 Sep, 2029
UBRELVY 11925709 Jan, 2035
VAFSEO 10149842 Nov, 2034
VAFSEO 11065237 Nov, 2034
VAFSEO 11324734 Mar, 2036
VAFSEO 11844756 Mar, 2036
VAFSEO 11857543 Jun, 2034
VAFSEO 8323671 Apr, 2028
VAFSEO 8598210 Jun, 2027
VAFSEO 8940773 Jun, 2027
VAFSEO 9701636 Nov, 2034
VAFSEO 9987262 Nov, 2034
VAFSEO RE47437 Jun, 2027
XOSPATA 11938130 Jul, 2036
XOSPATA 11938131 Jul, 2036
XOSPATA 11938132 Jul, 2036
XOSPATA 11938133 Jul, 2036
XOSPATA 11944620 Jul, 2036
ZEPBOUND 11357820 Jun, 2039
ZEPBOUND 11918623 Jun, 2039
ZEPBOUND 9474780 Jan, 2036
What's new on Pharsight!

Find the answers you need on Drugs.

Are you looking for accurate and reliable information on drugs and generics? Look no further! Our FAQ page is packed with answers to some of the most commonly asked questions about drugs. Visit and bookmark our FAQ page today!

Bonus - Don't see your question answered there? Contact us, and we'll be happy to help!

Check out FAQ page

Shoot first, and win big! Figure out the drugs that are about to enter the NCE-1 period to stay ahead of your generic launch strategy!

Want to be first-to-market with your generic drugs? Stay ahead of the game with our exclusive list of drugs facing patent challenges updated every month.

Check out NCE-1 period list

spacer_11

Our insights are consumed by 1000+ leading pharma companies

© 2024 GreyB Research